Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Las Vegas, Nevada 89135


Purpose:

This study will evaluate the safety and efficacy of MCS110 in patients with prostate cancer and bone metastases


Criteria:

Inclusion Criteria: - Patients with asymptomatic castrate-resistant prostate cancer with bone metastases who have not received any bisphosphonates in the 12 months prior to enrollment - 18 years old and over Exclusion Criteria: - Plan to be on cytotoxic or biologic therapy during study - Active dental problems - Active heart complications - Active infection - Patients with moderate to severe swelling due to fluid Other protocol-defined inclusion/exclusion criteria may apply


NCT ID:

NCT00757757


Primary Contact:

Study Director
Novartis Pharmaceuticals
Novartis Pharmaceuticals


Backup Contact:

N/A


Location Contact:

Las Vegas, Nevada 89135
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.